## AIZ: Assurant, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Quality metrics strong (ROE 15%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.0% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($214.85)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Why Is Assurant (AIZ) Up 1.8% Since Last Earnings Report?**
- Source: sharewise.com | 20251204T160736 | Bullish | Relevance: 100%
- Assurant (AIZ) has seen its shares rise 1.8% since its last earnings report, outperforming the S&P 500. The company reported strong Q3 2025 results, with net operating income and total revenues exceeding estimates due to solid performance in Global Housing and Global Lifestyle segments. Analysts maintain a positive outlook for AIZ, assigning it a Zacks Rank #2 (Buy) and anticipating above-average returns in the coming months.

**2. Consumers Trade Up for AI: Assurant Reports Record $1.59 Billion Returned in Third Quarter Through Mobile Trade-In Programs**
- Source: Business Wire | 20251204T130835 | Bullish | Relevance: 100%
- Assurant's Q3 Mobile Trade-In and Upgrade Industry Trends Report reveals a record $1.59 billion returned to consumers through mobile trade-in programs, marking a 46% year-over-year increase. This surge is attributed to consumers trading in devices earlier to adopt new AI-enabled smartphones, driving growth in the secondary market. The report highlights the dominance of 5G devices in trade-ins and their impact on the circular economy.

**3. Assurant (NYSE: AIZ) reports record $1.59B Q3 trade-ins as value returned jumps 46% YoY**
- Source: Stock Titan | 20251204T130215 | Bullish | Relevance: 100%
- Assurant (NYSE: AIZ) announced a record-breaking Q3 for its mobile trade-in programs, returning $1.59 billion to consumers, a 46% year-over-year increase. This surge is attributed to consumers trading in devices for newer AI-enabled smartphones, driving growth in the secondary market. The company projects surpassing last year's record total value returned, benefiting both affordability and sustainability.

**4. Consumers Trade Up for AI: Assurant Reports Record $1.59 Billion Returned in Third Quarter Through Mobile Trade-In Programs**
- Source: Markets Financial Content | 20251204T080000 | Bullish | Relevance: 100%
- Assurant reports a record $1.59 billion returned to consumers through mobile trade-in programs in Q3, a 46% year-over-year increase, driven by the adoption of AI-enabled devices. Year-to-date, $4.17 billion has been returned, with 5G devices dominating trade-ins and fueling the circular device economy. This trend highlights consumers' preference for newer, AI-powered smartphones and contributes to the growth of the secondary market.

**5. Assurant (NYSE: AIZ) sees BNY Mellon disclose 10.2% beneficial stake**
- Source: Stock Titan | 20251205T200750 | Neutral | Relevance: 100%
- The Bank of New York Mellon Corporation has filed an amended Schedule 13G, disclosing a 10.2% beneficial ownership in Assurant, Inc. (AIZ), totaling 5,091,314 shares. This ownership is held in various fiduciary capacities by BNY Mellon and its subsidiaries, with no single other person exceeding a 5% interest. The filing explicitly states that the shares were acquired in the ordinary course of business and not for the purpose of influencing control over Assurant.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-20 | Keefe, Bruyette | $254 | $248 | +2% |
| 2025-11-17 | Morgan Stanley | $248 | $232 | +7% |
| 2025-11-10 | UBS | $257 | $255 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-20 | Keefe, Bruyette | main | Outperform |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |
| 2025-11-10 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.10M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 55.5% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 1 / 9 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-2.0%)
- Bank Of New York Mel: 10.0% (+23.7%)
- Blackrock Inc.: 7.9% (-0.4%)
- T. Rowe Price Invest: 7.7% (-3.5%)
- State Street Corpora: 5.4% (-3.9%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +3%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Balance sheet: strong liquidity (11492000000.0x). Institutional flow bearish (9 selling vs 1 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $12.1B |
| Beta | 0.57 |
| 52W Range | $174.97 - $243.75 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 10.7 |
| Current P/E | 11.4 |
| YoY Growth | 6.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.2% to -3.2% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 7.2pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.08x) but short-term weakness (below SMA20). MACD histogram bearish (-0.86), momentum weakening. RSI neutral at 51. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.22% (CS: 26) | Weak |
| RSI_14 | 50.6 | Neutral |
| MACD Histogram | -0.86 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 1.018x | Above |
| vs SMA200 | 1.085x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $222.87
- **Stop Loss:** $214.85 (3.6% risk)
- **Target:** $238.91 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 124
- **Position Value:** $27,635.88
- **Portfolio %:** 27.64%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-10 (Est: $5.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.28 | $5.73 | +34.0% |
| 2025Q2 | $4.45 | $5.10 | +14.5% |
| 2025Q1 | $2.78 | $3.39 | +22.1% |
| 2024Q4 | $4.13 | $4.79 | +15.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*